FRAMINGHAM, Mass. and
SYDNEY, April 15, 2013 /PRNewswire/ -- HeartWare
International, Inc. (NASDAQ: HTWR, ASX:HIN) has scheduled a
conference call to discuss its financial results for the three
months ended March 31, 2013, at
5:00 p.m. U.S. Eastern Daylight Time
on Monday, April 29, 2013. The
Company plans to release the financial results prior to the
conference call.
The conference call with management will discuss the Company's
financial results, highlights from the first quarter and business
outlook. The call may be accessed by dialing 1-877-941-4774
five minutes prior to the scheduled start time and referencing
"HeartWare." For callers outside the U.S., please dial
+1-480-629-9760.
A live webcast of the call will also be available at the
Company's website (www.heartware.com) by selecting "HeartWare First
Quarter 2013 Conference Call" under the section titled "Corporate
Presentations" on the Home Page. A replay of the conference
call will be available through the above weblink immediately
following completion of the call.
A copy of the news release announcing results and related
information will be available on the Company's website,
www.heartware.com.
About HeartWare International
HeartWare International develops and manufactures miniaturized
implantable heart pumps, or ventricular assist devices, to treat
Class IIIB / IV patients suffering from advanced heart failure.
The HeartWare® Ventricular Assist System features
the HVAD® pump, a small full-support circulatory assist
device designed to be implanted next to the heart, avoiding the
abdominal surgery generally required to implant competing
devices. The HeartWare System is approved in the United States for the intended use as a
bridge to cardiac transplantation in patients who are at risk of
death from refractory end-stage left ventricular heart failure, and
has received CE Marking in the European Union and has been used to
treat patients in 27 international countries. The device is
also currently the subject of a U.S. clinical trial for destination
therapy. For additional information, please visit the
Company's website at www.heartware.com.
HeartWare International, Inc. is a member of the Russell
2000® and its securities are publicly traded on The
NASDAQ Stock Market and the Australian Securities Exchange.
HEARTWARE, HVAD, MVAD and HeartWare logos are registered
trademarks of HeartWare, Inc.
For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864
SOURCE HeartWare International, Inc.